HoldingsChannel.com
| Entity | Amount | Change
03/31/2023 to 06/30/2023 |
Position Size ($ in 1000's) |
|---|---|---|---|
 Seagen Inc. |
44,554,162 | -2,359,607 | $8,574,894 |
| SGEN | 44,554,162 | -2,359,607 | $8,574,894 |
| Incyte Corporation |
36,178,056 | +2,656 | $2,252,084 |
| INCY | 36,178,056 | +2,656 | $2,252,084 |
| BeiGene Ltd. |
11,668,897 | UNCH | $2,080,564 |
| BGNE | 11,668,897 | UNCH | $2,080,564 |
| ACADIA Pharmaceuticals Inc. |
42,864,612 | +926,126 | $1,026,607 |
| ACAD | 42,864,612 | +926,126 | $1,026,607 |
| Madrigal Pharmaceuticals Inc. |
1,545,113 | UNCH | $356,921 |
| MDGL | 1,545,113 | UNCH | $356,921 |
| BioMarin Pharmaceutical Inc. |
3,810,248 | UNCH | $330,272 |
| BMRN | 3,810,248 | UNCH | $330,272 |
| Immunocore Holdings plc |
2,520,731 | UNCH | $151,143 |
| IMCR | 2,520,731 | UNCH | $151,143 |
 Invitae Corporation |
$145,036 | ||
| Note 1 | 300,000,000 | +300,000,000 | $135,000 |
| NVTA | 8,881,104 | UNCH | $10,036 |
| Kodiak Sciences Inc. |
17,310,490 | UNCH | $119,442 |
| KOD | 17,310,490 | UNCH | $119,442 |
| Akero Therapeutics Inc. |
2,368,378 | UNCH | $110,580 |
| AKRO | 2,368,378 | UNCH | $110,580 |
| argenx SE |
280,159 | UNCH | $109,186 |
| ARGX | 280,159 | UNCH | $109,186 |
| Rhythm Pharmaceuticals Inc. |
6,498,267 | UNCH | $107,156 |
| RYTM | 6,498,267 | UNCH | $107,156 |
| Replimune Group Inc. |
4,578,280 | UNCH | $106,308 |
| REPL | 4,578,280 | UNCH | $106,308 |
| AbCellera Biologics Inc. |
16,450,180 | +6,000,000 | $106,268 |
| ABCL | 16,450,180 | +6,000,000 | $106,268 |
| Kymera Therapeutics Inc. |
4,375,340 | +1,495,515 | $100,589 |
| KYMR | 4,375,340 | +1,495,515 | $100,589 |
| Roivant Sciences Ltd. |
9,428,592 | +4,651,162 | $95,040 |
| ROIV | 9,428,592 | +4,651,162 | $95,040 |
| BioCryst Pharmaceuticals Inc. |
12,710,818 | UNCH | $89,484 |
| BCRX | 12,710,818 | UNCH | $89,484 |
| SpringWorks Therapeutics Inc. |
2,999,846 | +246,344 | $78,656 |
| SWTX | 2,999,846 | +246,344 | $78,656 |
| Entrada Therapeutics Inc. |
4,865,819 | UNCH | $73,668 |
| TRDA | 4,865,819 | UNCH | $73,668 |
| Revolution Medicines Inc. |
2,691,493 | UNCH | $71,997 |
| RVMD | 2,691,493 | UNCH | $71,997 |
| Immatics N.V. |
5,640,816 | +453,735 | $65,095 |
| IMTX | 5,640,816 | +453,735 | $65,095 |
| Chinook Therapeutics Inc. |
1,455,202 | UNCH | $55,909 |
| KDNY | 1,455,202 | UNCH | $55,909 |
| Mirati Therapeutics Inc. |
1,409,784 | UNCH | $50,935 |
| MRTX | 1,409,784 | UNCH | $50,935 |
| DICE Therapeutics Inc. |
1,035,786 | UNCH | $48,123 |
| DICE | 1,035,786 | UNCH | $48,123 |
| Biomea Fusion Inc. |
2,108,949 | UNCH | $46,291 |
| BMEA | 2,108,949 | UNCH | $46,291 |
| Prelude Therapeutics Inc. |
10,123,824 | UNCH | $45,557 |
| PRLD | 10,123,824 | UNCH | $45,557 |
| Denali Therapeutics Inc. |
1,455,322 | +366,584 | $42,947 |
| DNLI | 1,455,322 | +366,584 | $42,947 |
| Kiniksa Pharmaceuticals Ltd. |
2,809,577 | +10,000 | $39,559 |
| KNSA | 2,809,577 | +10,000 | $39,559 |
| Cerus Corporation |
16,067,558 | UNCH | $39,526 |
| CERS | 16,067,558 | UNCH | $39,526 |
| Nurix Therapeutics Inc. |
3,882,125 | UNCH | $38,782 |
| NRIX | 3,882,125 | UNCH | $38,782 |
| Ultragenyx Pharmaceutical Inc. |
783,059 | +312,085 | $36,123 |
| RARE | 783,059 | +312,085 | $36,123 |
| Aerovate Therapeutics Inc. |
1,963,479 | UNCH | $33,674 |
| AVTE | 1,963,479 | UNCH | $33,674 |
| IGM Biosciences Inc. |
3,157,210 | +554 | $29,141 |
| IGMS | 3,157,210 | +554 | $29,141 |
| Xenon Pharmaceuticals Inc. |
751,639 | UNCH | $28,938 |
| XENE | 751,639 | UNCH | $28,938 |
| ImmunoGen Inc. |
1,520,097 | +1,520,097 | $28,684 |
| IMGN | 1,520,097 | +1,520,097 | $28,684 |
| DBV Technologies S.A. |
14,614,264 | UNCH | $27,767 |
| DBVT | 14,614,264 | UNCH | $27,767 |
| Verve Therapeutics Inc. |
1,416,530 | UNCH | $26,560 |
| VERV | 1,416,530 | UNCH | $26,560 |
| 2seventy bio Inc. |
2,497,526 | UNCH | $25,275 |
| TSVT | 2,497,526 | UNCH | $25,275 |
| IDEAYA Biosciences Inc. |
1,062,123 | +229,354 | $24,960 |
| IDYA | 1,062,123 | +229,354 | $24,960 |
| Stoke Therapeutics Inc. |
2,130,238 | +14,822 | $22,644 |
| STOK | 2,130,238 | +14,822 | $22,644 |
| Bicycle Therapeutics plc |
843,814 | UNCH | $21,534 |
| BCYC | 843,814 | UNCH | $21,534 |
| Monte Rosa Therapeutics Inc. |
3,023,951 | +2,648,856 | $20,714 |
| GLUE | 3,023,951 | +2,648,856 | $20,714 |
| Cabaletta Bio Inc. |
1,594,000 | +250,000 | $20,579 |
| CABA | 1,594,000 | +250,000 | $20,579 |
| Krystal Biotech Inc. |
169,934 | -132,782 | $19,950 |
| KRYS | 169,934 | -132,782 | $19,950 |
| Summit Therapeutics Inc. |
6,304,705 | UNCH | $15,825 |
| SMMT | 6,304,705 | UNCH | $15,825 |
| AnaptysBio Inc. |
775,924 | UNCH | $15,782 |
| ANAB | 775,924 | UNCH | $15,782 |
| Prime Medicine Inc. |
1,028,466 | UNCH | $15,067 |
| PRME | 1,028,466 | UNCH | $15,067 |
| Pacific Biosciences of California Inc. |
1,127,782 | UNCH | $15,000 |
| PACB | 1,127,782 | UNCH | $15,000 |
| Relay Therapeutics Inc. |
1,160,117 | +876,117 | $14,571 |
| RLAY | 1,160,117 | +876,117 | $14,571 |
| ARS Pharmaceuticals Inc. |
2,006,451 | UNCH | $13,443 |
| SPRY | 2,006,451 | UNCH | $13,443 |
See Full List: All Stocks Held By Baker BROS. Advisors LP
— Including:
• Biggest new positions
• Biggest exits
• Biggest increased positions
• Biggest decreased positions
See Details: Top 10 Stocks Held By Baker BROS. Advisors LP
|
Size ($ in 1000's)
At 06/30/2023: $17,279,236 At 03/31/2023: $18,379,744 Baker BROS. Advisors LP holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from Baker BROS. Advisors LP 13F filings. Link to 13F filings: SEC filings |
